This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Dexamethasone as Adjuvant to Bupivacaine in Suprazygomatic Maxillary Nerve Block

Sponsored by Assiut University

About this trial

Last updated 2 years ago

Study ID

suprazygomatic maxillary nerve

Status

Not yet recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
1 to 9 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 4 months ago

What is this trial about?

Postoperative pain score, Faces, Legs, Activity, Cry, Consolability (FLACC) is the primary outcome. The secondary outcomes are the first-time requested analgesia, the number of children required analgesia, the total amount of analgesic requirements during first the 24 hours.

What are the participation requirements?

Yes

Inclusion Criteria

- Age between 1 and 9 years

- Children scheduled for primary surgery for soft palate cleft or soft and hard palate clefts

- Gender: both

- ASA grade I - II.

- Informed consent.

No

Exclusion Criteria

- Parent refusal

- History of developmental delay or mental retardation, which will make observational pain intensity assessment difficult

- Hypersensitivity to any local anesthetics

- Bleeding diathesis

- Children with co-morbid conditions like congenital heart disease, respiratory pathology and central nervous system disorders

- Skin lesions or wounds at the puncture site of the proposed block